Study Confirms No Benefit to Taking Fluvoxamine for COVID-19 Symptoms
A study led by the Duke Clinical Research Institute (DCRI) in partnership with Vanderbilt University found no symptomatic or clinical benefit to taking the antidepressant fluvoxamine at a dosage of 100 mg twice daily for 13 days for the treatment of mild-to-moderate COVID-19 symptoms.
STAR Students Complete Ninth-Annual Research Training Program
A group of promising young scientists completed the ninth annual Duke STAR Program in August, after spending the summer building research skills and working side-by-side with Duke University faculty to research medications and how they are being used.
New Blood Test Detects a Key Indicator of Parkinson’s Disease
Researchers have developed a blood test that detects Parkinson’s disease, potentially establishing a way to help diagnose the condition before nervous system damage worsens.
DCRI ‘Science of Diversity’ Interns Share Lessons Learned
The first cohort of Duke Clinical Research Institute’s newest internship program, the Science of Diversity in Clinical Trials (SDCT), celebrated the conclusion of the program by presenting the importance of community engagement in clinical research, lessons learned, and their personal journeys to the program’s faculty and staff and partners in July.
Intravenous Iron Treatment Provides Some Benefit to Patients with Heart Failure and Iron Deficiency
Despite numerical improvements in mortality, hospitalizations and exercise ability, data did not reach the pre-specified level of statistical significance.
Newly published research explores impact of COVID-19 on hospitalized infants
Newly published research led by the Pediatrix Medical Group and the Duke Clinical Research Institute’s Rachel Greenberg, MD, MB, MHS assessed the impact of COVID-19 on pregnant women and infants admitted to the neonatal intensive care unit (NICU). It is believed to be the largest study evaluating the prevalence of COVID-19 within a diverse neonatal population and associated hospital outcomes.
Duke Clinical Research Institute launches long COVID trials through NIH RECOVER Long COVID Initiative
The design of the clinical trials will allow comparison of multiple interventions across symptom areas for people living with long COVID.
ABC Science Collaborative, RADx-UP publish lessons learned about keeping children safe in school during COVID-19 pandemic
The ABC Science Collaborative and RADx-UP have published a special supplement to the research journal Pediatrics focused on lessons learned while navigating the K-12 school environment during the pandemic.
DCRI Announces 2023 Excellence Award Winners
The Duke Clinical Research Institute celebrated its staff and faculty who shine the way forward on Tuesday, June 13, announcing the winners of the inaugural DCRI Excellence Awards at the organizati
DCRI Announces New Partnership With Novo Nordisk To Fight Cardiovascular Disease
A new partnership with leading global healthcare company Novo Nordisk and the Duke Clinical Research Institute